Man Held With 200 Banned Injections Awarded 12-Year Jail Term

Chandigarh : The Chandigarh district court has sentenced a man arrested with 200 banned injections to 12 years of rigorous imprisonment.

The special court judge Rajiv K Beri also imposed a ₹1.20 lakh fine on Yadwinder Singh, who was convicted under Section 22 (c) of the Narcotic Drugs and Psychotropic Substances (NDPS) Act.

According to the prosecution, a police team was on patrolling duty near the Electricity Office, in Sector 41, on February 15, 2018 when around 9.30 pm they saw the accused walking towards them with a yellow polythene bag in his right hand. But on spotting the police, he panicked and started walking away.

On frisking him, the cops found 100 injections of buprenorphine (2 ml each) and 100 injections of pheniramine maleate (10 ml each) in his possession. As Singh could not produce any permit for the injections, he was booked under Section 22 of the Narcotic Drugs and Psychotropic Substances (NDPS) Act.

The defence counsel submitted that the accused was falsely implicated, and was shown to be arrested from Chandigarh, which was incorrect.

Holding the accused guilty, the court observed, “The nature of offence and recovery of multi-times commercial quantity of 198.8 g of contraband containing buprenorphine from the conscious possession of the convict does not leave any reason with the court to treat him with leniency.”

“It may give the wrong signal to society, thereby, encouraging propagation of delivery and possession of such psychotropic substances which are hazardous, damaging and are potential reasons for spoiling youth,” the court added in its order dated August 23.

  • Related Posts

    • Pharma
    • June 17, 2025
    • 74 views
    Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda

    Telangana:  Natco Pharma has appointed Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda of the Company. Yarramshetty Krishna Rao has overall 33 years of experience in the…

    • Pharma
    • June 16, 2025
    • 102 views
    Natco API plant gets one observation from FDA

    Hyderabad: Drugmaker, Natco Pharma, Mekaguda-based Active Pharmaceutical Ingredients (API) plant has received one observation under the form 483 from the US Food and Drug Administration (FDA). In a stock exchange…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda

    Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda

    Natco API plant gets one observation from FDA

    Natco API plant gets one observation from FDA

    Pharma department refuses to name 30 doctors in bribery tangle

    Pharma department refuses to name 30 doctors in bribery tangle

    Delhi Police busts fake cancer drugs racket

    Delhi Police busts fake cancer drugs racket